期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 123, 期 9, 页码 3967-3982出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI65570
关键词
-
资金
- NIH (NIAID) [AAD-CRC U19-AI070489, MRCE U54-AI05160]
- ATS/COPD Foundation
- Children's Discovery Institute
- Martin Schaeffer Fund
- NIH (NHLBI) [P01-HL29594, R01-HL073159, CADET P50-HL107183, K08-HL083095]
Chronic obstructive lung disease is characterized by persistent abnormalities in epithelial and immune cell function that are driven, at least in part, by infection. Analysis of parainfluenza virus infection in mice revealed an unexpected role for innate immune cells in IL-13-dependent chronic lung disease, but the upstream driver for the immune axis in this model and in humans with similar disease was undefined. We demonstrate here that lung levels of IL-33 are selectively increased in postviral mice with chronic obstructive lung disease and in humans with very severe chronic obstructive pulmonary disease (COPD)). In the mouse model, IL-33/IL-33 receptor signaling was required for Il13 and mucin gene expression, and Il33 gene expression was localized to a virus-induced subset of airway serous cells and a constitutive subset of alveolar type 2 cells that are both linked conventionally to progenitor function. In humans with COPD, IL33 gene expression was also associated with IL13 and mucin gene expression, and IL33 induction was traceable to a subset of airway basal cells with increased capacities for pluripotency and ATP-regulated release of IL-33. Together, these findings provide a paradigm for the role of the innate immune system in chronic disease based on the influence of long-term epithelial progenitor cells programmed for excess IL-33 production.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据